A Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Study, and QT Interval Study of HRS-5965 Capsules in Healthy Subjects

NCT06684041 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemolytic Anemia

Interventions

DRUG: HRS-5965 capsule
DRUG: HRS-5965 capsule placebo

Sponsor

Chengdu Suncadia Medicine Co., Ltd.